Loading
Total declarations
Company
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Latest filing published 02 May 2022 for BIOLASE, INC. Read the official filing
Filing timeline
BuySaleJohn R. Beaver
Insider track record
Disclosed buys
3
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
John R. Beaver: trading record in brief
John R. Beaver, listed as chief executive, appears in our data through filings on Biolase, Inc shares, published by SEC (Form 4). Over a trading history stretching from 19 May 2021 to 28 April 2022, the count stands at 4 filings.
The open-market record is one-sided, with 3 purchases worth €71k and not one sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
Half of the purchases are above €25k and half below. None of the 3 purchases we analysed coincided with buying by another insider of the same company within 30 days.
On 2 May 2022 came the latest disclosure, a transaction in Biolase, Inc. The last insider purchase was made public on 2 December 2021, 1,781 days ago. Typically, a trade is published a median of 3 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to John R. Beaver
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
554.794 sharesSeries G Preferred StockSEC:0000899243-22-016094:0
70,000 shares@ US$0.4539.4% of flowCommon StockSEC:0001209191-21-067673:0
Canonical exit: 28 Feb 2022 (T+90)
35,000 shares@ US$0.6125.8% of flowCommon StockSEC:0001209191-21-052884:0
Canonical exit: 18 Nov 2021 (T+90)
40,000 shares@ US$0.7534.8% of flowCommon StockSEC:0001209191-21-033957:0
Canonical exit: 17 Aug 2021 (T+90)
4 of 4 declarations
